Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,313–1,320 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Cocrystal Pharma Inc. CC-42344 Influenza A Phase 2a Ongoing Oral Antiviral
Cocrystal Pharma Inc. CC-42344 Influenza A Phase 2a Ongoing Oral Antiviral
Cocrystal Pharma Inc. CC-31244 Hepatitis C Phase 2a Looking for Funding Oral Antiviral
Cogent Biosciences Inc. Bezuclastinib and SUTENT (sunitinib) - (PEAK) Gastrointestinal Stromal Tumors (GIST) NDA Filing Trial Planned Oral Oncology
Cogent Biosciences Inc. Bezuclastinib - (SUMMIT) Non-Advanced Systemic Mastocytosis NDA Filing Data Released oral Immunology
Cogent Biosciences Inc. Bezuclastinib - (APEX) Advanced Systemic Mastocytosis Phase 2 Data Released Oral Oncology
Cognition Therapeutics Inc. Zervimesine (CT1812) - (SHINE) Mild-to-Moderate Alzheimer's Disease Phase 3 Trial Planned Oral Neurology
Cognition Therapeutics Inc. CT1812 - (SEQUEL) Mild-to-Moderate Alzheimer's Disease Phase 2 Trial Completed Oral Neurology